DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Melarsoprol is an investigational drug.
There have been 3 clinical trials for Melarsoprol. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2001.
The most common disease conditions in clinical trials are Trypanosomiasis, African, Trypanosomiasis, and [disabled in preview]. The leading clinical trial sponsors are Epicentre, Drugs for Neglected Diseases, and World Health Organization.
Recent Clinical Trials for Melarsoprol
|Efficacy and Safety of Fexinidazole in Patients With Human African Trypanosomiasis (HAT) Due to Trypanosoma Brucei Rhodesiense||European and Developing Countries Clinical Trials Partnership (EDCTP)||Phase 2/Phase 3|
|Efficacy and Safety of Fexinidazole in Patients With Human African Trypanosomiasis (HAT) Due to Trypanosoma Brucei Rhodesiense||Drugs for Neglected Diseases||Phase 2/Phase 3|
|Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis||Embassy of France in Uganda||Phase 3|